Malta set to benefit from landmark overhaul of EU pharma rules

The EU’s first major reform of pharmaceutical legislation in more than two decades is expected to improve access to medicines in Malta, with new rules obliging manufacturers to supply smaller and island Member States on request and introducing a multilingual digital patient information system that will allow Maltese authorities to source medicines